Value-Based Costing of Anti-Cancer Drugs: An Ethical Perspective Grounded in Catholic Teachings on Human Dignity and the Common Good
{{output}}
Americans have benefited from a declining cancer incidence and improving prognosis over the past two decades, during which time rising prices for anti-cancer drugs have proportionally outstripped rising expenditures for overall cancer care and total national h... ...
